Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Ramkissoon SH, Fernandes H, Lopez-Terrada DH, Hameed MR, Trembath DG, Bridge JA, et al. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors. Arch Pathol Lab Med. 2022.

Man L, Guahmich NL, Kallinos E, Caiazza B, Khan M, Liu Z-, et al. Chronic superphysiologic AMH promotes premature luteinization of antral follicles in human ovarian xenografts. Sci Adv. 2022;8(10):eabi7315.

Suryawanshi H, Yang H, Lubetzky M, Morozov P, Lagman M, Thareja G, et al. Detection of infiltrating fibroblasts by single-cell transcriptomics in human kidney allografts. PLoS One. 2022;17(6):e0267704.

Chen J, San SS, Kung A, Tomasek M, Liu D, Rodgers W, et al. Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing. PLoS One. 2022;17(2):e0263868.

Orea-Soufi A, Paik J, Bragança J, Donlon TA, Willcox BJ, Link W. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci. 2022;43(12):1070-1084.

van der Mijn JC, Eng KW, Chandra P, Fernandez E, Ramazanoglu S, Sigaras A, et al. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. Mol Oncol. 2022;16(12):2384-2395.

Magro C, Grossman ME, Karaaslan S, Skrokov R, Valinotti M. Localized pemphigus vegetans of the nose and lips: A classic case of a rare entity. JAAD Case Rep. 2022;25:67-71.

Burns D, Anokian E, Saunders EJ, Bristow RG, Fraser M, Reimand J, et al. Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. Eur Urol. 2022;82(2):201-211.

Guo P, Liu Y, Geng F, Daman AW, Liu X, Zhong L, et al. Publisher Correction: Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptability. Nat Cell Biol. 2022;24(2):279.

Linares JF, Cid-Diaz T, Duran A, Osrodek M, Martinez-Ordoñez A, Reina-Campos M, et al. The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62. Cell Rep. 2022;39(6):110792.